Washington, DC (July 17, 2026) — As the market for unregulated peptide products continues to grow, the American Pharmacists Association (APhA) is urging FDA and the Pharmacy Compounding Advisory Committee (PCAC) to prioritize patient safety, scientific evidence

WASHINGTON, DC — Every year, millions of visitors make their way to the Lincoln Memorial, pausing to admire one of America's most iconic landmarks. Few realize that directly across the street sits one of Washington's most unique historic buildings, the only privately owned structure on the National Mall.

Washington, DC  (May 22, 2026) — The American Pharmacists Association (APhA) is deeply concerned by the removal of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). For decades, USPSTF has served as a trusted, nonpartisan authority providing rigorous, evidence-based recommendations that guide preventive care and screenings across the health care system. 

Washington, DC (May 21, 2026) — The American Pharmacists Association (APhA), joined by state and national pharmacy associations, applauds the U.S. House Ways and Means Committee for advancing H.R. 3164, the Main Street Pharmacy Access Act, common-sense legislation that ensures seniors can receive pharmacist-provided care in their communities. 

WASHINGTON, DC (April 9, 2026) — The American Pharmacists Association (APhA) is pleased to announce that Melissa Somma McGivney, PharmD, FCCP, FAPhA, will join the organization as its inaugural Chief of Professional and Member Experience, effective June 1, 2026.